{"id":21326,"date":"2021-12-21T11:40:20","date_gmt":"2021-12-21T09:40:20","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=21326"},"modified":"2021-12-21T11:40:20","modified_gmt":"2021-12-21T09:40:20","slug":"pleciamos-asmenu-grupes-galincios-nemokamai-issitirti-covid-19-antikunus","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2021\/12\/21\/pleciamos-asmenu-grupes-galincios-nemokamai-issitirti-covid-19-antikunus\/","title":{"rendered":"Ple\u010diamos asmen\u0173 grup\u0117s, galin\u010dios nemokamai i\u0161sitirti COVID-19 antik\u016bnus"},"content":{"rendered":"<p><strong>Nuo gruod\u017eio 17 dienos vienas nemokamas kiekybinis ar pusiau kiekybinis serologinis tyrimas atliekamas ir asmenims, kurie persirgo COVID-19 liga ir buvo vakcinuoti viena \u201eComirnaty\u201c, \u201eSpikevax\u201c ar \u201eVaxzevria\u201c vakcinos doze ne anks\u010diau kaip po 120 dien\u0173 nuo vakcinos suleidimo.<\/strong><\/p>\n<p>Vien\u0105 kart\u0105 nemokamas kiekybinis ar pusiau kiekybinis serologinis tyrimas ir toliau bus atliekamas asmenims, vakcinuotiems pagal piln\u0105 vakcinacijos schem\u0105, kurie dar n\u0117ra paskiepyti sustiprinan\u010di\u0105ja \u201eComirnaty\u201c, \u201eSpikevax\u201c ar \u201eCOVID-19 Vaccine Janssen\u201c vakcinos doze ar n\u0117ra sirg\u0119 COVID-19 (neturi diagnoz\u0117s, patvirtintos teigiamu SARS-CoV-2 PGR tyrimo rezultatu). Serologinis tyrimas atliekamas ne anks\u010diau kaip po 120 dien\u0173 nuo vakcinos suleidimo.<\/p>\n<p>Asmuo, pasiskiepij\u0119s pagal piln\u0105 vakcinacijos schem\u0105 yra asmuo, pasiskiepij\u0119 dviem vakcinos doz\u0117mis, jeigu skiepijosi \u201eComirnaty\u201c, \u201eSpikevax\u201c, \u201eVaxzevria\u201c vakcinomis arba viena \u201eCOVID-19 Vaccine Janssen\u201c vakcinos doze.<\/p>\n<p>Nemokami kiekybiniai ar pusiau kiekybiniai serologiniai tyrimai taip pat atliekami vaikams nuo 12 iki 16 met\u0173. Jiems \u0161is tyrimas atliekamas nepriklausomai nuo to, ar jie yra vakcinuoti ar sirg\u0119 COVID-19 liga. Atliekam\u0173 tyrim\u0173 skai\u010dius vaikams yra neribojamas, ta\u010diau tyrim\u0105 kartoti galima ne da\u017eniau kaip kas 30 dien\u0173.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" src=\"https:\/\/i0.wp.com\/sam.lrv.lt\/uploads\/sam\/documents\/images\/NEMOKAMAS%20ANTIK%C5%AAN%C5%B2%20TYRIMAS.png?w=1200&#038;ssl=1\" alt=\"\" \/><\/p>\n<p>Serologiniam tyrimui atlikti imamas kraujo m\u0117ginys. Tyrimo rezultatas parodo paciento kraujyje esan\u010dio imuninio atsako \u012f virus\u0105 produktus \u2013 antik\u016bnus, susidariusius \u017emogaus organizme, vystantis imuniniam atsakui \u012f koronaviruso infekcij\u0105. Rezultatai gali pad\u0117ti apsispr\u0119sti d\u0117l skiepijimosi nuo COVID-19 sustiprinan\u010di\u0105ja doze.<\/p>\n<p>Sveikatos apsaugos ministerija visiems asmenims, kuriems pra\u0117jo daugiau nei 4 m\u0117n. po pilno pasiskiepijimo rekomenduoja neatid\u0117lioti sprendimo ir pasiskiepyti sustiprinan\u010di\u0105ja doze.<br \/>\nGavus teigiam\u0105 kiekybinio ar pusiau kiekybinio serologinio tyrimo rezultat\u0105 asmeniui bus formuojamas Galimybi\u0173 pasas, kuris galioja 60 dien\u0173.<\/p>\n<p>\u012estaig\u0173, atliekan\u010di\u0173 nemokamus kiekybinius ar pusiau kiekybinius serologinius tyrimus, s\u0105ra\u0161as skelbiamas <a href=\"https:\/\/sam.lrv.lt\/lt\/koronavirusas\/informacija-visuomenei\/mobilieji-punktai-karsciavimo-klinikos-ir-laboratorijos\">\u010cIA<\/a>.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" src=\"https:\/\/i0.wp.com\/sam.lrv.lt\/uploads\/sam\/documents\/images\/NEMOKAMAS%20ANTIK%C5%AAN%C5%B2%20TYRIMAS%20%20%284%29.png?w=1200&#038;ssl=1\" alt=\"\" \/><\/p>\n<p><a href=\"https:\/\/sam.lrv.lt\/lt\/kontaktai-ziniasklaidai\"><em>SAM Spaudos tarnyba<\/em><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nuo gruod\u017eio 17 dienos vienas nemokamas kiekybinis ar pusiau kiekybinis serologinis tyrimas atliekamas ir asmenims, kurie persirgo COVID-19 liga ir buvo vakcinuoti viena \u201eComirnaty\u201c, \u201eSpikevax\u201c ar \u201eVaxzevria\u201c vakcinos doze ne anks\u010diau kaip po 120 dien\u0173 nuo vakcinos suleidimo. Vien\u0105 kart\u0105 nemokamas kiekybinis ar pusiau kiekybinis serologinis tyrimas ir toliau bus atliekamas asmenims, vakcinuotiems pagal piln\u0105&hellip;<\/p>\n","protected":false},"author":3,"featured_media":21327,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-21326","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-5xY","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2021\/12\/19699_c9959d9ff9dee3ea4b62e419408782de.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/21326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=21326"}],"version-history":[{"count":2,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/21326\/revisions"}],"predecessor-version":[{"id":21329,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/21326\/revisions\/21329"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/21327"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=21326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=21326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=21326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}